Howe & Rusling Inc Bausch Health Companies Inc. Transaction History

Howe & Rusling Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $18,814 - $23,730	-818 Reduced 89.11%	100 $3,000
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $4,206 - $5,050	168 Added 22.4%	918 $26,000
Q2 2021 Aug 13, 2021	SELL	$27.43 - $32.7 $90,244 - $107,583	-3,290 Reduced 81.44%	750 $22,000
Q4 2020 Feb 08, 2021	BUY	$15.31 - $21.12 $61,852 - $85,324	4,040 New	4,040 $84,000

252

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.63B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.